Both in Biotechnology
MiNK Therapeutics vs Cognition Therapeutics
Over the past year INKT returned −17.5% and CGTX returned −57.9%; their daily moves had a correlation of 0.01.
INKT −17.5% CGTX −57.9%Growth of $1, one year, split-adjusted
| Metric | INKT | CGTX |
|---|---|---|
| Price | $11.10 | $0.6906 |
| Market cap | $56.6M | $65.7M |
| Today | +0.54% | −2.68% |
| 1 month | −9.0% | −26.4% |
| 6 months | −3.8% | −44.3% |
| Year to date | −0.4% | −48.8% |
| 1 year | −20.9% | −61.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.8M | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 50.9% | 48.0% |
| Short % of float | 2.4% | 8.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).